Page last updated: 2024-08-24

emitefur and Stomach Neoplasms

emitefur has been researched along with Stomach Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, F; Fujita, M; Inaba, H; Taguchi, T1
Maehara, Y; Sugimachi, K1
Fujii, S; Fujita, F; Fujita, M; Fukushima, M; Shirasaka, T; Taguchi, T1

Trials

1 trial(s) available for emitefur and Stomach Neoplasms

ArticleYear
A phase II trial of a new 5-fluorouracil derivative, BOF-A2 (Emitefur), for patients with advanced gastric cancer.
    Surgery today, 2000, Volume: 30, Issue:12

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Disease Progression; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Analysis; Treatment Outcome

2000

Other Studies

2 other study(ies) available for emitefur and Stomach Neoplasms

ArticleYear
[Antitumor activity of BOF-A2, a new 5-fluorouracil derivative, against human cancers xenografted in nude mice by intermittent administration].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:2

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Stomach Neoplasms; Tegafur; Uracil

1993
[Antitumor activity and metabolism of BOF-A2, a new 5-fluorouracil derivative, with human cancers xenografted in nude mice].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:9

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Colorectal Neoplasms; Fluorouracil; Humans; Liver; Mice; Mice, Nude; Microsomes; Neoplasm Transplantation; Neoplasms, Experimental; Pancreatic Neoplasms; Stomach Neoplasms

1990